References
Iseda N, Itoh S, Yoshizumi T et al (2021) Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma. Int J Clin Oncol 26(10):1890–1900
Miyata T, Hayashi H, Yamashita YI et al (2022) The impact of histologic liver inflammation on oncology and the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 29(2):893–902
Muller X, Mohkam K, Mabrut JY (2021) Inflammation is king in liver resection for hepatocellular carcinoma. Hepatobiliary Surg Nutr 10(6):839–841
Foerster F, Gairing SJ, Müller L et al (2022) NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options. J Hepatol 76(2):446–457
Shimada S, Kamiyama T, Orimo T et al (2021) High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection. Hepatobiliary Surg Nutr 10(4):454–463
El-Domiaty N, Saliba F, Karam V et al (2021) Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up. Hepatobiliary Surg Nutr 10(5):598–609
Author information
Authors and Affiliations
Contributions
All authors conceived and reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors disclose no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Liu, X., Du, S. Letter to the Editor: Inflammation influences the prognosis of hepatocellular carcinoma. Int J Clin Oncol 27, 1791–1792 (2022). https://doi.org/10.1007/s10147-022-02234-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-022-02234-5